Evidence map›Paper›PMID 38851849›Full record

ArticleCommunications chemistry2024

Ratiometric nonfluorescent CRISPR assay utilizing Cas12a-induced plasmid supercoil relaxation.

Noor Mohammad, Logan Talton, Selen Dalgan, Zach Hetzler, Anastasiia Steksova, Qingshan Wei

Abstract read
In one paragraph

Article in Communications chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Attomolar Detection of HIV-1 With Label-Free RCA-rCRISPR on Smartphone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Noor MohammadDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA.
Logan TaltonDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA.
Selen DalganDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA.
Zach HetzlerDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA.
Anastasiia SteksovaDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA.
Qingshan WeiDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC, 27695, USA. qwei3@ncsu.edu.ORCID http://orcid.org/0000-0003-1214-010X

Funding

National Science Foundation (NSF) 1944167
6 · The paper itself

Abstract

Most CRISPR-based biosensors rely on labeled reporter molecules and expensive equipment for signal readout. A recent approach quantifies analyte concentration by sizing λ DNA reporters via gel electrophoresis, providing a simple solution for label-free detection. Here, we report an alternative strategy for label-free CRISPR-Cas12a, which relies on Cas12a trans-nicking induced supercoil relaxation of dsDNA plasmid reporters to generate a robust and ratiometric readout. The ratiometric CRISPR (rCRISPR) measures the relative percentage of supercoiled plasmid DNA to the relaxed circular DNA by gel electrophoresis for more accurate target concentration quantification. This simple method is two orders of magnitude more sensitive than the typical fluorescent reporter. This self-referenced strategy solves the potential application limitations of previously demonstrated DNA sizing-based CRISPR-Dx without compromising the sensitivity. Finally, we demonstrated the applicability of rCRISPR for detecting various model DNA targets such as HPV 16 and real AAV samples, highlighting its feasibility for point-of-care CRISPR-Dx applications.

Identifiers

PMID38851849
PMCPMC11162422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.